Abstract:Abstract A 66-year-old man was referred urgently to dermatology from ophthalmology with a short history of developing multiple pigmented lesions on the trunk and in the axillae, the concern being that he had developed a malignant melanoma. He had been under their care for almost a year with a history of a subacute decline in vision in both eyes leading to ‘tunnel vision’. His medical history was complex and included acute myeloid leukaemia secondary to myelodysplastic syndrome treated with fludarabine, melphalan and alemtuzumab (FMA) reduced-intensity sibling allograft. Following bone marrow transplant and chemotherapy, he had post-transplant complications including cytomegalovirus reactivation, cytopenia secondary to splenomegaly, and possible graft-versus-host disease (bronchiolitis obliterans and brachial plexitis). He had presented to ophthalmology with his vision at 6/12 and 6/9 in the right and left eye, respectively. On examination, there were poorly reactive pupils with normal pupil reflexes and normal colour vision in both eyes. The visual field to confrontation was significantly constricted. Optical coherence tomography scans demonstrated outer retinal loss in the parafoveal region with macular oedema in both eyes. An autoimmune retinopathy was suspected due to these findings. Electrodiagnostic tests were consistent with this. A secondary survey was undertaken, and a positron emission tomography scan showed no evidence of active acute myeloid leukaemia or other malignancy. Neuroimaging demonstrated generalized cortical atrophy with no acute intracranial abnormalities. He was treated for a presumed nonparaneoplastic autoimmune retinopathy. He was commenced on dexamethasone intravitreal implants and mycophenolate mofetil 1 g twice a day. At review, as well as him having multiple seborrhoeic keratoses, there was an atypical melanocytic lesion on the back, which was excised urgently. This proved to be a malignant melanoma in situ with extensive regression; subsequent re-excision revealed no residual tumour. Therefore, he was diagnosed with presumed melanoma-associated retinopathy (MAR) and commenced on monthly intravenous immunoglobulin 1.5g kg−1. On subsequent visits he subjectively felt his vision had remained stable with no further deterioration. MAR is a rare paraneoplastic ocular condition. This is an autoimmune retinopathy, where a molecular mimicry occurs between the neuroectodermally derived melanocytes and the retinal proteins. MAR can precede the diagnosis of malignant melanoma, with other initial investigations being negative. This case highlights the importance of referring patients for a thorough dermatology examination for an individual presenting with an autoimmune retinopathy. With early detection and treatment, irreversible immune-related retinal damage and associated visual loss can be mitigated.

CHOROIDAL NEOVASCULARIZATION AND CHORIORETINAL ATROPHY IN A PATIENT WITH MELANOMA-ASSOCIATED RETINOPATHY AFTER IPILIMUMAB/NIVOLUMAB COMBINATION THERAPY

NIVOLUMAB-INDUCED HARADA-LIKE UVEITIS WITH BACILLARY DETACHMENT MIMICKING CHOROIDAL METASTASIS

BILATERAL CHOROIDAL DETACHMENTS SECONDARY TO IPILIMUMAB AND PEMBROLIZUMAB USE

Periocular granulomatous inflammatory lesions mimicking conjunctival melanoma recurrence in the setting of systemic nivolumab treatment

Melanoma-associated retinopathy treated with ipilimumab therapy

Acute exudative polymorphous vitelliform maculopathy during pembrolizumab treatment for metastatic melanoma: a case report

ACUTE EXUDATIVE PARANEOPLASTIC POLYMORPHOUS VITELLIFORM MACULOPATHY DURING VEMURAFENIB AND PEMBROLIZUMAB TREATMENT FOR METASTATIC MELANOMA

CHOROIDAL NEOVASCULAR MEMBRANES ASSOCIATED WITH PAPILLITIS IN A PATIENT ON CHECKPOINT INHIBITOR

Bilateral Drug-Induced Uveitis and Epiretinal Membrane during the Treatment of a Metastatic Cutaneous Melanoma

Primary Treatment of Eyelid Conjunctival Melanoma with Immunotherapy: A Case Report

Treatment of Nocardia Chorioretinitis Related Choroidal Neovascularization with Aflibercept: A Case of Unveiled Immunocompromise with anti-GM-CSF Antibodies

Case report: Conjunctival melanoma treated with relatlimab and nivolumab showing remarkable response

Punctate inner choroiditis and choroidal neovascular membrane formation following vitreoretinal surgery: A case report

Immune-related keratitis is a rare complication associated with nivolumab treatment in a patient with advanced colorectal cancer: A case report

Successful Use of Intravitreal Bevacizumab and Methotrexate in a Case of Neovascularization of the Iris and Pseudohypopyon Secondary to Recurrent Diffuse Large B-Cell Lymphoma

Choroidal neovascular membrane associated with unilateral retinitis pigmentosa

Poster presentationsDS12 A rare ophthalmological consequence of cutaneous malignant melanoma

Vogt-Koyanagi-Harada syndrome-like uveitis after nivolumab administration as a treatment for ovarian cancer

Choroidal Response to Intravitreal Bevacizumab Injections in Treatment-Naïve Macular Neovascularization Secondary to Chronic Central Serous Chorioretinopathy

Case report: A rare case of immunotherapy induced isolated left CN VI palsy in a patient with unresectable melanoma

Cancer-associated retinopathy after anti-programmed death 1 (PD-1) antibody for treating hepatocellular carcinoma——a case report of a Chinese patient